drugset / Trial / NCT00063791

A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE

NCT00063791 ↗

Expanded access No longer available Millennium Pharmaceuticals, Inc.

Summary

The purpose of this study is to give patients who have had 4 or more prior lines of therapy for multiple myeloma access to VELCADE. The study is for patients who are not eligible for other clinical trials with VELCADE and for who VELCADE would otherwise not be available.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Bortezomib Small molecule — —

Indications